Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of neuroactive drugs targeting central nervous system disorders. Its fluorinated pyrrolidine structure enhances metabolic stability and blood-brain barrier penetration, making it valuable in designing potent and selective enzyme inhibitors or receptor modulators. Commonly employed in the production of experimental therapeutics for psychiatric and neurological conditions due to its stereochemical purity and functional group compatibility in multi-step synthesis.